Iovance Biotherapeutics, Inc.

IOVA

Find Out if You Qualify for a Financial Reward by filling out the form below.

Iovance Biotherapeutics, Inc. Form












Breaking News Stocks does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

On December 27, 2023, Iovance announced that, on December 22, 2023, the U.S. Food and Drug Administration (“FDA”) had placed a clinical hold on the Company’s IOV-LUN-202 trial, which was investigating the Iovance’s lead product candidate for the treatment of metastatic non-small cell lung cancer. Iovance advised that the FDA’s decision to place the clinical hold was “in response to a recently reported Grade 5 (fatal) serious adverse event potentially related to the non-myeloablative lymphodepletion pre-conditioning regimen.”

On this news, Iovance’s stock price fell 18.67% to close at $7.23 per share on December 27, 2023.

Find More Cases

Ticker SymbolCompany NameJoin DeadlineJoin
TDOCTeladoc Health, Inc.July 16, 2024Join
VSTSVestis CorporationJuly 16, 2024Join
CMBMCambium Networks CorporationJuly 22, 2024Join
BIIBBiogen Inc.July 22, 2024Join
FSLYFastly, Inc.July 23, 2024Join
ENPHEnphase Energy, Inc.July 29, 2024Join
RIVNRivian Automotive, Inc.July 30, 2024Join
HTZHertz Global Holdings, Inc.July 30, 2024Join
HUMHumana Inc.August 02, 2024Join
MRNSMarinus Pharmaceuticals, Inc.August 05, 2024Join
SMGThe Scotts Miracle-Gro CompanyAugust 05, 2024Join
GRTSGritstone bio, Inc.August 06, 2024Join
RBLXRoblox CorporationAugust 12, 2024Join
TWOU2U, Inc.August 12, 2024Join
LWLamb Weston Holdings, Inc.August 12, 2024Join
TDCTeradata CorporationAugust 13, 2024Join
NKENIKE, Inc.August 19, 2024Join
PATHUiPath, Inc.August 19, 2024Join
FFFutureFuel Corp.August 23, 2024Join
TMToyota Motor CorporationAugust 23, 2024Join
SRGSeritage Growth PropertiesAugust 30, 2024Join
MDBMongoDB, Inc.September 09, 2024Join
WBAWalgreens Boots Alliance, Inc.September 10, 2024Join
CVSCVS Health CorporationSeptember 10, 2024Join